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Background
Fetal hemoglobin (HbF) levels in different hemoglobin variants in Osogbo, Nigeria, were 
estimated using two principal methods of estimation using existing information for HbF 
concentration and distribution of various hemoglobin variants in the area, as well as diag-
nosed cases of thalassemia. Two hundred and sixty samples collected from HbSS, HbSC, 
HbAA, HbAS, and HbAC subjects were analyzed. HbF level and hemoglobin type were 
determined in this study. 
Methods
The hemoglobin type was determined using cellulose acetate electrophoresis at an alka-
line pH, and HbF was determined by the acid elution and alkaline denaturation methods. 
Results
The mean±SD of HbF in the respective hemoglobin variants was as follows: HbSS, 
2.09±1.94%; HbSC, 0.85±0.54%; HbAA, 0.69±0.46%; HbAS, 0.52±0.31%; and HbAC, 
0.57±0.26%. The mean HbF level across the hemoglobin variants was statistically sig-
nificant (P＜0.05). Investigating the sex distribution of the HbF level in the studied pop-
ulation revealed a slightly higher mean HbF level in females than in their male counter-
parts. 
Conclusion
Within the study population, the HbF level was found to be highest in HbSS and lowest 
in HbAS. The two methods of estimating HbF are equally reliable, since there was no sig-
nificant difference between the results obtained from the two methods.
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INTRODUCTION
  Inherited hemoglobin disorders are the most common sin-
gle gene disorders, estimated by the World Health Organiza-
tion (WHO) to be carried by approximately 7% of the world’s 
population. Some of these diseases, particularly sickle-cell 
anemia and the more severe forms of thalassemia, cause 
life-threatening medical emergencies, chronic disability to 
families, and a major drain on health resources [1]. However, 
patients with severe inherited disorders of β-globin chain 
structure or synthesis, in particular sickle cell anemia and 
β-thalassemia (β-thal), may have a milder illness if they 
produce unusually high levels of fetal hemoglobin (HbF) 
[2]. This β-globin chain structure disorder comprises a heter-
ogeneous group of conditions, in which HbF production 
persists through adult life in the absence of hematological 
abnormalities called hereditary persistence of fetal hemoglo-
bin (HPFH) [3]. Persistent production of variable levels of 
HbF into childhood and adult life is a characteristic finding 
in sickle cell anemia and more severe forms of β-thal. HbF 
levels are also useful for predicting the clinical severity of 
sickle cell disease (SCD) [4].
Hemoglobin is a tetrameric protein compound made up 
of a complex of four polypeptide chains and four heme groups. 
It is the oxygen-carrying molecule of RBC, and it makes 
up approximately 95% of the RBC proteins [5]. Of this protein 
population, normal adult blood is about 96-98% HbAA, with 
the molecular structure α2β2, up to 3.5% HbA 2, with the 
molecular structure α2δ2, and less than 1% HbF [6]. HbF, 
with a molecular structure of α2γ2, is heterogeneous, with 
two types of γ-chains that differ in their amino acid composi-Korean J Hematol 2011;46:118-22.
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tion, having either glycine (γ
G chains) or alanine (γ
A chains) 
at position 136. The γ
G and γ
A chains are the products of 
separate loci. HbF comprises less than 1% of hemoglobin 
in normal adults and has a high affinity for oxygen due 
to its inability to interact with 2,3-diphosphoglycerate [1]. 
High oxygen affinity of HbF allows it to bind to oxygen 
more avidly than normal hemoglobin, leading to tissue hypo-
xia and, in turn, increased erythropoietin and an elevated 
mass of RBCs. The resistance to acid elution and alkaline 
denaturation seen in fetal cells is attributed to the presence 
of HbF [7]. 
Over 300 structural hemoglobin variants have been de-
scribed, most of which result from single amino acid sub-
stitutions [8]. Many of these variants, which are not asso-
ciated with disease conditions, were discovered during a 
survey of the electrophoretic patterns of human hemo-
globins. These abnormal hemoglobins can be classified based 
on the type of underlying mutation or according to their 
clinical consequences. The heterozygous state is called the 
trait and the homozygous conditions are called the disease; 
for example, patients with heterozygous HbS (genotype AS) 
are said to have the sickle cell trait, while the homozygous 
HbS state (genotype SS) is the SCD. Examples of structural 
hemoglobin variants include HbS, HbD, Punjab, HbE, HbH, 
HbM, HbBart, HbG Philadelphia, and HbHasheron [9-12].
  Using existing information about the HbF concentration 
and distribution in various hemoglobin variants in Osogbo, 
Nigeria, the aims of this study were to determine the HbF 
levels of normal (AA), sickle cell trait (AS), SCD (SS), com-
pound heterozygous state (SC), and AC subjects and to eval-
uate the results of the two principal methods of estimating 
HbF level and the sex distribution in the study area. We 
also provide information on the underdiagnosis of thalasse-
mia cases in this area, owing to limited facilities and re-
sources.
MATERIALS AND METHODS
1. Study area and collection of samples
The study was conducted at the Hematology Department 
Laboratory of the Ladoke Akintola University of Technology 
Teaching Hospital (LTH), Osogbo, Osun State, Nigeria. The 
260 study subjects consisted of 80 HbAA, 40 HbAS, 20 HbAC, 
80 HbSS, and 40 HbSC. Subjects in crises, as well as those 
on HbF reactivators, were excluded from the study using 
questionnaires. Informed consent was obtained from the par-
ticipating subjects with ethical approval from the appropriate 
committee of our institution. The samples were collected 
between July and October 2010. Approximately 2.5 mL of 
blood was collected into a bottle containing 0.04 mL of 
ethylenediamine tetra acetic acid (EDTA) as an anticoagu-
lant. The blood was well mixed with the anticoagulant and 
analyzed immediately or stored at 4
oC for subsequent 
analysis.
2. Cellulose acetate paper electrophoresis 
Five microliters of lysed sample was transferred into well 
plates using a unit applicator; the sample was applied into 
the cellulose acetate membrane, along with suitable controls, 
and immediately placed in the electrophoresis chamber. The 
chamber was connected to a power supply and electro-
phoresed for 15 min at 350 V. This was used to separate 
and identify the different hemoglobins by their migration 
within an electric field. The amino acid composition of hemo-
globin variants results in differences in their surface electrical 
charges, corresponding to different separation rates. Good 
separation of HbA, HbF, HbS, and HbC was obtained using 
this technique [13].
3. Acid elution cytochemical method 
Fresh blood films were prepared. These were air dried, 
fixed in 80% ethanol for 5 min, rinsed rapidly, and then 
air dried on blotting paper for 10 min. They were then 
placed in elution solution for 20 s, rinsed thoroughly in 
water, counterstained for 2 min, rinsed in water, and air 
dried. Slides were observed microscopically using a ×100 
objective to count the number of fetal cells per 1,000 ghost 
cells [7].
4. Alkali denaturation 
A solution of hemoglobincyanide (HiCN) was prepared 
by adding 0.25 mL of hemolysate to 4.75 mL cyanide solution; 
2.8 mL of HiCN solution was transferred to glass test tubes 
and 0.2 mL of 1.2 mol/L NaOH was added and mixed for 
3 s. After 2 min, 2 mL of saturated ammonium sulfate solution 
was added to each tube and mixed for 10 min. The solution 
was filtered twice through the same Whatman no. 42 filter 
paper, and the filtrate (the alkali-resistant hemoglobin) was 
obtained. HiCN solution (0.4 mL) was diluted with 13.9 
mL of water to obtain total hemoglobin, and its absorbance, 
as well as the absorbance of the alkali-resistant hemoglobin, 
was measured spectrophotometrically at 420 nm against wa-
ter blank. The percentage alkali-resistant hemoglobin was 
calculated as follows:
% Alkali-resistant 
hemoglobin [14]=
A420 alkali-resistant Hb×100
A420 total Hb×20
5. Statistical analysis 
A paired t-test was used for the data analysis with pie 
and box plot representations constructed using SPSS version 
16. P＜0.05 denotes a significant difference between groups.
RESULTS
The HbF levels in the different hemoglobin variants in-
volved in this study are shown in Table 1 and Figs. 1-4. 
Table 1 represents the mean±SD of HbF in the different 
hemoglobin variants (HbSS, HbSC, HbAA, HbAS, and 
HbAC), along with their respective subjects’ population. The Korean J Hematol 2011;46:118-22.
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Table 1. The mean+S.D HbF level in different hemoglobin variants 
in the studied population.
Hemoglobin types
HbF (%)
(Acid elution 
method)
HbF (%)
(Alkaline 
denaturation 
method)
P
SS N 80 78 79
1.98±1.96 2.09±1.94 ＞0.05
SC N 40 38 40
0.75+0.61 0.85+0.53 ＞0.05
AA N8 0 7 7 8 0
0.48±0.43 0.69±0.46 ＞0.05
AS N 40 37 40
0.35±0.23 0.52±0.31 ＞0.05
AC N 20 20 20
0.37±0.19 0.57±0.26 ＞0.05
Data are given as Mean+SD. Comparison of the two methods was
done using paired 't' test method. "P＜0.05" denotes significant 
difference between the two methods.
Fig. 1. Percentage distribution of hemoglobin variants in the studied 
population using cellulose acetate paper electrophoresis.
Fig. 2. Hemoglobin F concentrations using cytochemical acid elution 
method in different hemoglobin variants.
Fig. 3. Age distribution of Hb SS variants with Hb F concentration 
obtained from using cytochemical acid elution method.
table also highlights and compares HbF concentration in 
the test hemoglobin types, showing results of the cytochem-
ical acid elution and alkaline denaturation methods. There 
was no significant difference between results obtained using 
the two methods for estimating HbF levels, cytochemical 
acid elution and alkaline denaturation. Fig. 1 displays the 
distribution of respective hemoglobin variants for the 260 
subjects studied.
Fig. 2 shows variations in the HbF concentrations in differ-
ent hemoglobin variants, with HbSS showing the highest 
variability of greater than 1 SD. A normal distribution of 
HbF concentration was observed in other hemoglobin var-
iants, HbSC, HbAA, HbAS, and HbAC, since they have a 
lower SD. A high level of HbF was observed in the HbSS 
variant (Fig. 2) for the 1-10 and 11-20 years age groups. 
The 20-30 years age group had a normal distribution of 
HbF (Fig. 3).
Fig. 4A shows the effect of sex on the distribution of 
HbF in HbSS subjects. The figure shows that females had 
higher HbF levels than the male counterparts. The combina-
tion of gender and age distribution of the mean HbF level 
in the studied HbSS variant population is shown in Fig. 
4B. In the 1-10 years age group, males had a higher HbF 
distribution than females; this trend reversed in the 11-20 
years age group, in which females had higher HbF levels 
than males.
DISCUSSION
The HbSS variant was observed to have the highest mean± 
SD HbF level (2.09±1.94%), followed by HbSC (0.85±0.54%), 
HbAA (0.69±0.46%), HbAS (0.52±0.31%), and HbAC (0.57± 
0.26%), with statistically significant differences among the 
hemoglobin types (P＜0.05) (Table 1). When the HbF levels 
were estimated in 130 sickle cell anemia patients in Ibadan, 
Nigeria, using the alkaline denaturation technique, the mean 
HbF level was 5.9±3.8% [15]. A similar study performed Korean J Hematol 2011;46:118-22.
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Fig. 4. (A) Gender effect on the mean Hb F level as obtained using cytochemical acid elution method in Hb SS variant. (B) Gender and age 
distributions of the mean Hb F level obtained using cytochemical acid elution method among the studied population of Hb SS variant.
in Calabar, Nigeria, reported that the mean HbF value in 
HbSS subjects was higher (3.05±1.61%) than in HbA and 
HbAS subjects, with means±SD of 0.20±0.25% and 1.07± 
0.98%, respectively, and with a statistically significant mean 
HbF (P＜0.02) [16]. HbF levels in healthy Nigerian adults, 
as assessed by the alkaline denaturation method, were 
2.70±3.40% (mean±SD) in individuals with HbA and 2.40± 
2.20% (mean±SD) in HbAS subjects; this high level of HbF 
in healthy adults was reported to be genetic [4]. Additionally, 
in a similar study conducted among adult Nigerians with 
SCD, [4] the mean±SD HbF value was 7.40±3.60%; however, 
the distribution was not significant. Previous findings from 
other groups corroborate the results from this study. The 
variations in the HbF levels in HbSS patients and others 
from different localities could be due to common single- 
nucleotide polymorphisms (SNPs) at the BCL11A  and 
HBS1L-MYB loci, which have been implicated previously 
in HbF level variation in non-anemic European populations 
[17]. An association between a BCL11A SNP and HbF levels 
in a SCD cohort study in the USA has also recently been 
demonstrated. A report on human HbF expression also sup-
ports this claim, suggesting that the BCL 11A gene is a poten-
tial regulator of HbF expression [18].
In our study, the mean HbF level was higher in females 
than in males, with female HbSS and HbSC subjects having 
the highest mean HbF level (Fig. 2). This is in agreement 
with a study showing that, after the age of 10, HbF levels 
were consistently higher in females than in males, and this 
was statistically significant (Fig. 4B) [19]. The difference 
between males and females was suspected to be due to the 
hormonal effects of puberty. In a study estimating HbF levels 
in SCD, male sickle cell patients were found to have sig-
nificantly lower levels of HbF than their female counterparts 
(Fig. 4A) [15]. In a similar study, males were found to have 
higher HbF levels (7.6±3.9%) than their female counterparts 
(6.7±3.6%), but the difference was not statistically significant 
[4]. When age is considered, the 1-10-year age group had 
the highest mean HbF level among all hemoglobin genotypes, 
with the exception of HbAC. The 21-30-year age range had 
the lowest HbF levels among all hemoglobin genotypes ex-
cept for HbAC (Fig. 2 and 3), and the relationship was statisti-
cally significant (P＜0.05). In a study comparing the hemato-
logical indices in homozygous sickle cell patients, it was 
discovered that beyond age 10, there is no consistent age-re-
lated trend in HbF levels [20].
When the two methods to estimate HbF level (the acid 
elution method and the alkaline denaturation method) were 
compared, there was no difference between the results ob-
tained from the two methods. These methods were well 
correlated, and this implies that either method can be reliably 
used to estimate HbF levels (Table 1).
In conclusion, the HbF level is higher in SS subjects com-
pared with subjects with other hemoglobin variants. This 
increased HbF level is a compensatory mechanism for sick-
ling in SS subjects [2]. Further investigations into the diag-
nosis of co-existent thalassemia among subjects are recom-
mended. 
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